期刊文献+

多发性骨髓瘤MRI骨髓浸润模式与血管生成关系的研究 被引量:3

Study on the correlation between MRI patterns of marrow involvement and angiogenesis in myeloma
下载PDF
导出
摘要 目的:探讨多发性骨髓瘤MRI骨髓浸润模式与血管生成的相关性。方法:以25例初诊MM患者为研究对象,进行传统影像学、血清肌酐、血清蛋白、β2微球蛋白、乳酸脱氢酶等检测,并根据Durie-Salmon分期系统进行分期。对骨髓瘤患者在初诊及治疗之前行脊柱T1WI、STIR和常规的T1WI增强扫描,分析骨髓瘤细胞在骨髓内的浸润模式。对照组包括非恶性血液病患者10例,其骨髓涂片及活检检查均证实为正常骨髓象。对研究组和对照组患者均进行骨髓活检及病理检查,免疫组化测定微血管密度(MVD),以CD34单抗标记微血管内皮细胞。另外,采集骨髓后分离上层血浆,采用ELISA法测定VEGF蛋白浓度,根据结果进行统计学分析。结果:初治MM患者骨髓上清VGEF水平及MVD高于健康对照组(P<0.05)。MRI骨髓弥漫性浸润的MM患者骨髓上清VGEF水平及MVD高于MRI骨髓成像正常或局灶性浸润的患者(P<0.05)。结论:MRI骨髓弥漫性浸润模式与血管生成密切相关。 Objective:To explore correlations between MRI patterns of marrow involvement and bone marrow an-giogenesis in myeloma. Methods:Twenty-five newly diagnosed myeloma patients were enrolled in this study. The level of serum creatinine,albumin,β2-micoglobulin,and Lactate Dehydrogenase were routinely detected. The pres-ence of bone involvement was documented with conventional skeletal surveys. Durie-Salmon staging system was ap-plied for staging. Spinal marrow were examined with MR imaging. T1-weighted images(T1WI),short TI inversion re-covery(STIR)and enhanced T1WI were performed and analyzed for patterns of myelomatous involvement. 10 pait-ients with non-malignant hemotopoietic diaseases were enrolled in the control group,whose bone marrow were ap-proved to be not involved through bone marrow smear and biopsy. Microvessel density( MVD)was determined by im-munohistochemical identification of microvascular endothelial cells in the bone marrow trephine biopsies using a hu-man monoclonal antibody against CD34. In addition,An enzyme-linked immunosorbent assay was used for the detec-tion of the serum vascular endothelial growth factor( VEGF). Results:The serum levels of VEGF and MVD in bone marrow of newly-diagnosed MM increased significantly compared with the control(P〈0. 05). The extent of angio-genesis,as assessed by MVD in trephine biopsies and serum levels of VEGF increased in myeloma patients with dif-fuse MRI bone marrow pattern compared with patients with normal or focal pattern(P〈0. 05). Conclusion:Diffuse MRI marrow pattern correlates with increased angiogenesis.
出处 《现代肿瘤医学》 CAS 2014年第10期2436-2439,共4页 Journal of Modern Oncology
基金 山东省济宁市科技局立项课题(编号:济科成鉴字[2013]第57号)
关键词 多发性骨髓瘤 MRI 骨髓微血管密度 血管内皮生长因子 myeloma MRI microvessel density vascular endothelial growth factor
  • 相关文献

参考文献14

  • 1张之南,沈悌.血液病诊断及疗效标准[J ].北京:科学出版社,2013:232 -235.
  • 2向东,罗天友,吴景全,史斌,袁书伟,吕发金.脊椎多发性骨髓瘤的MRI表现与鉴别诊断[J].重庆医科大学学报,2006,31(5):725-727. 被引量:2
  • 3Walker R,Barlogie B,Haessler J,et al. Magnetic resonance imagingin multiple myeloma : diagnostic and clinical implications [ J ]. J Clin0ncol,2007,25(9) :1121 -1128.
  • 4Moulopoulos LA,Gika D, Anagnostopoulos A,et al. Prognostic sig-nificance of magnetic resonance imaging of bone marrow in previ-ously untreated patients with multiple myeloma [ J ] . Ann Oncol,2005,16(11):1824 -1828.
  • 5杨晓萍,张茜,刘光耀,王跃军.脊柱多发性骨髓瘤的MR诊断价值[J].解放军医药杂志,2013,25(8):58-60. 被引量:9
  • 6Mariette X,Zagdanski AM,Guermazi A,et al. Prognostic value ofvertebral lesions detected by magnetic resonance imaging in pa-tients with stage I multiple myeloma [ J ]. Br J Haematol, 1999,104(4):723 -729.
  • 7陈任政,张刚,成官迅,张雪林.多发性骨髓瘤的临床与影像诊断[J].南方医科大学学报,2009,29(4):811-813. 被引量:14
  • 8Dimopoulos MA,Moulopoulos LA,Datseris I,et al. Imaging of mye-loma bone disease - implications for staging, prognosis and follow -up[J]. Acta Oncol,2000,39(7) :823 -827.
  • 9Bannas P,Kroger N’Adam G,et al. Modem imaging techniques inpatients with multiple myeloma[ J] . Rofo,2013 ,185( 1 ) :26 -33.
  • 10黄斌,钟醒怀,黄永杰,江万荣.多发性骨髓瘤的临床及影像学分析[J].昆明医学院学报,2005,26(4):103-106. 被引量:10

二级参考文献33

  • 1李守静,李宏然,赵相印,李清朗.多发性骨髓瘤诊断的探讨(附2547例分析)[J].中华肿瘤杂志,1995,17(1):43-46. 被引量:151
  • 2丁建平,任庆云,李彦格,康胜群,刘秀健,赵静品,封彦祥,王溱.92例多发性骨髓瘤临床X线分析[J].中华放射学杂志,1996,30(8):567-569. 被引量:15
  • 3International Myeloma Working Group. Criteria for classification of monoclonal gammopathies, multiple myeloma and related disorder: report of the International Myeloma Working Group [J]. Br J Haematol, 2003, 121(5): 749-57.
  • 4LeCouvet FE, Malghem J, Michaux L, et al. Skeletal survey in advanced multiple myeloma: radiographic versus MR imaging survey[J ]. Br J Haematol, 1999, 106(1): 35-9.
  • 5Horger M, Kanz L, Denecke B, et al. The benefit of using wholebody, low-dose, nonenhanced, multidetector computed tomography for follow up and therapy response monitoring in patients with multiple myeloma[J]. Cancer, 2007, 109(8): 1617-26.
  • 6李景学 孙鼎元.骨关节X线诊断学[M].北京:人民卫生出版社,1996.494-495.
  • 7WOOLFENDEN J M, PITT M J, DURIE B G M,et al. Comparison of bone scintigraphy and radiography in multiple myefoma [ J ]. Radiology, 1982,134 : 723.
  • 8武忠弼.病理学[M].北京:人民卫生出版社,1993.62
  • 9徐爱德.骨关节CT和MRI[M].济南:山东科学技术出版社,2002; 80-90.
  • 10Stabler A,Baur A,Bartl R,et al.Contrast enhancement and quantitative signal analysis in MR imaging of multiple myeloma:assessment of focal and diffuse growth patterns in marrow correlated with biopsies and survival rates[J].AJR,1996; 167 (4):1029-1036.

共引文献31

同被引文献23

  • 1李娟,赵莹,张殿宝,黄蓓晖.Survivin在多发性骨髓瘤患者骨髓细胞中的表达及其临床意义[J].癌症,2005,24(12):1522-1526. 被引量:13
  • 2姜海波,李猛,贺亮.26例多发性骨髓瘤的X线、CT诊断分析[J].医药前沿,2011,1(22):25.
  • 3Tsubaki M,Takeda T,Ogawa N,et al.Overexpression of survivin via activation of ERK1/2,Akt,and NF-kappaB plays a central role in vincristine resistance in multiple myeloma cells[J].Leuk Res,2015,39(4):445-452.
  • 4Zeng W,Meng F,Liu Z,et al.Bortezomib-based chemotherapy regimens can improve response in newly diagnosed multiple myeloma patients with bcl-2 and survivin overexpression[J].Int J Clin Exp Pathol,2014,7(7):4239-4246.
  • 5Neufeld G TS,Gitay-Goren H.Vascular endothelial growth factor (VEGF) and its receptors[J].The FASEB Journal,1994,5(1):89-97.
  • 6Andersen NF,Vogel U,Klausen TW,et al.Vascular endothelial growth factor (VEGF) gene polymorphisms may influence the efficacy of thalidomide in multiple myeloma[J].Int J Cancer,2012,131(5):E636-342.
  • 7R Seki SY,T Matsui TY.Pigment epithelium-derived factor (PEDF) inhibits survival and proliferation of VEGF-exposed multiple myeloma cells through its anti-oxidative properties[J].Biochem Biophys Res Commun,2013,431(4):693-697.
  • 8Valkovic T,Babarovic E,Lucin K,et al.Plasma levels of osteopontin and vascular endothelial growth factor in association with clinical features and parameters of tumor burden in patients with multiple myeloma[J].Biomed Res Int,2014,2014:513170.
  • 9Mesri M,Morales-Ruiz M,Ackermann EJ,et al.Suppression of vascular endothelial growth factor-mediated endothelial cell protection by survivin targeting[J].Am J Pathol,2001,158(5):1757-1765.
  • 10Romagnoli M,Trichet V,David C,et al.Significant impact of survivin on myeloma cell growth[J].Leukemia,2007,21(5):1070-1078.

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部